Some chronic obstructive pulmonary disease will originate in neonatal intensive care units

J R Bentham1, N J Shaw

  • 1Neonatal Unit, Liverpool Women's Hospital, Liverpool L8 7SS, UK.

Insights

Premature infants often develop chronic lung disease, leading to respiratory issues throughout childhood. Long-term outcomes and risks like smoking

Area of Science:

  • Neonatology
  • Pediatric Pulmonology
  • Respiratory Medicine

Background:

  • Prematurity is a significant risk factor for chronic lung disease in infants.
  • Survivors of prematurity frequently experience respiratory illnesses, hospitalizations, and persistent symptoms like cough and wheeze in their first year.
  • These infants often require supplemental oxygen, though needs decrease with lung maturation.

Purpose of the Study:

  • To summarize the long-term respiratory consequences for survivors of prematurity.
  • To highlight the persistent respiratory challenges faced by these children into adulthood.
  • To identify critical unanswered questions regarding long-term respiratory health in this population.

Main Methods:

  • Review of existing literature on respiratory outcomes in premature infants.
  • Analysis of imaging studies and longitudinal follow-up data (where available).
  • Identification of knowledge gaps concerning long-term respiratory health.

Main Results:

  • Chronic lung disease is the most common adverse outcome in premature infant survivors.
  • Childhood is marked by persistent wheeze, cough, and reduced exercise tolerance compared to peers.
  • Imaging suggests a high likelihood of adult respiratory problems similar to chronic obstructive pulmonary disease.

Conclusions:

  • Premature infants face a high burden of chronic respiratory morbidity throughout their lives.
  • Longitudinal data beyond adolescence is limited, necessitating further research.
  • Key unanswered questions include the long-term nature of these respiratory problems, the impact of smoking, and effects on life expectancy.

Related Concept Videos

Chronic Obstructive Pulmonary Disease01:24

Chronic Obstructive Pulmonary Disease

COPD is defined as a heterogeneous lung condition marked by persistent respiratory symptoms such as dyspnea, cough, and sputum production, caused by abnormalities in the airways that cause airflow obstruction.
Smoking is a primary risk factor for COPD, with over 80% of patients having a history of it. Patients typically experience progressive dyspnea or labored breathing, frequent coughing, and recurrent pulmonary infections. Many eventually succumb to respiratory failure, characterized by...
Pneumonia I: Introduction01:30

Pneumonia I: Introduction

Pneumonia is an acute respiratory infection that targets the lungs, specifically the alveoli. These tiny air sacs, essential for oxygen exchange, become engorged with pus and fluid, severely hindering breathing, decreasing oxygen absorption, and causing significant pain and discomfort during respiration.
Risk Factors
Various factors influence the likelihood of developing pneumonia. Age plays a crucial role, with infants, children under two, and individuals over 65 at increased risk due to their...
Chronic Obstructive Pulmonary Disease-I: Introduction01:20

Chronic Obstructive Pulmonary Disease-I: Introduction

Chronic Obstructive Pulmonary Disease (COPD) is a long-lasting respiratory condition requiring continuous attention and care. It is a progressive lung disease that leads to breathing challenges due to airflow obstruction. It manifests as persistent respiratory symptoms and restricted airflow resulting from abnormalities in the airways and alveoli, usually due to long-term exposure to harmful particles or gases. COPD mainly consists of two primary conditions: emphysema and chronic bronchitis.
Chronic Obstructive Pulmonary Disease I: Introduction01:23

Chronic Obstructive Pulmonary Disease I: Introduction

Chronic obstructive pulmonary disease is a common, preventable, and treatable respiratory disorder characterized by persistent symptoms and progressive airflow limitation. This limitation results from a combination of small-airway disease (obstructive bronchiolitis) and parenchymal destruction (emphysema), both driven by chronic inflammation from exposure to harmful particles or gases.The disease includes two main pathological entities: emphysema, marked by destruction of alveolar walls and...
Chronic Obstructive Pulmonary Disease III: Chronic Bronchitis Features01:24

Chronic Obstructive Pulmonary Disease III: Chronic Bronchitis Features

Chronic bronchitis is a key phenotype of chronic obstructive pulmonary disease (COPD), characterized by airway-centered inflammation and mucus overproduction. It develops from long-term exposure to harmful particles or gases, most commonly cigarette smoke, which triggers a persistent inflammatory response.Cellular and Structural ChangesInflammation initially affects the large bronchi and later the smaller airways, with infiltration by immune cells, including neutrophils, macrophages, and...
Pneumonia I: Introduction01:29

Pneumonia I: Introduction

Pneumonia is an infection of the lower respiratory tract that leads to inflammation of the lung parenchyma, often resulting in the accumulation of inflammatory exudate in the alveoli and airways. Unlike the watery, low-protein fluid exudate in pulmonary edema, the exudate in this case is a thick fluid rich in immune cells, proteins, and debris produced during infection and inflammation.This impairs gas exchange and can lead to consolidation of lung tissue. The infection may be caused by a...